CDSCO Panel Approves Wockhardt's Protocol Amendment Proposal for antimicrobial drug Cefepime plus Zidebactam Dr. Divya Colin3 Sept 2024 5:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved Wockhardt's...
Wanbury ropes in Prakash Venkatraman as President of API business Ruchika Sharma16 Aug 2024 3:53 PM ISTMumbai: Wanbury Limited has announced the appointment of Prakash Venkatraman as President of the API business. With a stellar career...
Wockhardt plans to launch antibiotic Zaynich in early FY26 Ruchika Sharma30 Jun 2024 2:00 PM ISTMumbai: Wockhardt said that research and trials for the antibiotic Zaynich are advancing well, with plans for an early launch in FY26. Habil...
Wockhardt raises Rs 480 crores via QIP Ruchika Sharma30 March 2024 1:15 PM ISTWith the closure of its recent Qualified Institutional Placement (QIP), Wockhardt has now raised Rs 480 crores. The share allotment committee allotted...
Wockhardt gets CDSCO Panel nod to study Biphasic insulin aspart Dr. Divya Colin15 March 2024 5:30 PM ISTNew Delhi: Reviewing the protocol presented by the drug major Wockhardt, the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Wockhardt loss narrows to Rs 86 crore in Q3 Ruchika Sharma17 Feb 2024 10:00 AM ISTNew Delhi: Pharmaceuticals firm Wockhardt Ltd has reported narrowing of consolidated net loss to Rs 86 crore for the third quarter ended December...
Wockhardt Gets CDSCO Panel Nod To study combination of cefepime and zidebactam. Dr. Divya Colin16 Jan 2024 5:00 PM ISTNew Delhi: The drug major Wockhardt has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Wockhardt gets CDSCO Panel Nod to study antimicrobial FDC Cefepime plus Tazobactum Dr. Divya Colin26 Nov 2023 3:45 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted permission to the...
Wockhardt shareholders reject resolution on related party transaction Ruchika Sharma18 Aug 2023 1:30 PM ISTNew Delhi: Shareholders of pharma firm Wockhardt Ltd have rejected a resolution on a related party transaction that seeks to allow the company to...
Wockhardt Former executive banned from securities market for six months for insider trading Ruchika Sharma21 Jun 2023 3:30 PM ISTNew Delhi: Sebi has barred Yatendra Kumar, a former executive of Wockhardt Ltd, from the securities market for six months and directed him to disgorge...
Present More Data on drug abuse potential of Tapentadol: CDSCO tells Wockhardt for FDC Dicyclomine,Tapentadol Dr. Divya Colin8 March 2023 5:15 PM ISTNew Delhi: Regarding the fixed dose combination (FDC) drug Dicyclomine plus Tapentadol, the Subject Expert Committee (SEC) functional under the...
Wockhardt plans to roll out two vaccines within year from UK facility as part of a tie-up with SII Ruchika Sharma27 Feb 2023 2:30 PM ISTNew Delhi: Drug firm Wockhardt plans to roll out two vaccines within a year from its UK-based facility as part of a tie-up with Serum Institute...
